194 related articles for article (PubMed ID: 32803686)
1. The synergistic anticancer effects of ReoT3D, CPT-11, and BBI608 on murine colorectal cancer cells.
Babaei A; Soleimanjahi H; Soleimani M; Arefian E
Daru; 2020 Dec; 28(2):555-565. PubMed ID: 32803686
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells loaded with oncolytic reovirus enhances antitumor activity in mice models of colorectal cancer.
Babaei A; Soleimanjahi H; Soleimani M; Arefian E
Biochem Pharmacol; 2021 Aug; 190():114644. PubMed ID: 34090878
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan.
Maitra R; Seetharam R; Tesfa L; Augustine TA; Klampfer L; Coffey MC; Mariadason JM; Goel S
Oncotarget; 2014 May; 5(9):2807-19. PubMed ID: 24798549
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.
Sei S; Mussio JK; Yang QE; Nagashima K; Parchment RE; Coffey MC; Shoemaker RH; Tomaszewski JE
Mol Cancer; 2009 Jul; 8():47. PubMed ID: 19594950
[TBL] [Abstract][Full Text] [Related]
5. The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone.
Shao Z; Wang H; Ren H; Sun Y; Chen X
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570646
[TBL] [Abstract][Full Text] [Related]
6. STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells.
Liu Y; Peng X; Li H; Jiao W; Peng X; Shao J; Xu Y; Wang R; Wang W; Kong D
Recent Pat Anticancer Drug Discov; 2021; 16(3):350-362. PubMed ID: 33655847
[TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.
Tang W; Su G; Li J; Liao J; Chen S; Huang C; Liu F; Chen Q; Ye Y
Int J Oncol; 2014 Sep; 45(3):995-1010. PubMed ID: 24968890
[TBL] [Abstract][Full Text] [Related]
8. Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage.
Bi S; Chen K; Feng L; Fu G; Yang Q; Deng M; Zhao H; Li Z; Yu L; Fang Z; Xu B
Eur J Pharmacol; 2019 Jul; 855():252-261. PubMed ID: 31085238
[TBL] [Abstract][Full Text] [Related]
9.
Babaei A; Bannazadeh Baghi H; Nezhadi A; Jamalpoor Z
Adv Pharm Bull; 2021 Feb; 11(2):361-370. PubMed ID: 33880359
[No Abstract] [Full Text] [Related]
10. Immune characterization of metastatic colorectal cancer patients post reovirus administration.
Parakrama R; Fogel E; Chandy C; Augustine T; Coffey M; Tesfa L; Goel S; Maitra R
BMC Cancer; 2020 Jun; 20(1):569. PubMed ID: 32552875
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
Heinemann L; Simpson GR; Boxall A; Kottke T; Relph KL; Vile R; Melcher A; Prestwich R; Harrington KJ; Morgan R; Pandha HS
BMC Cancer; 2011 Jun; 11():221. PubMed ID: 21645351
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Effect of Adipose Mesenchymal Stem Cells-Derived Secretome with and without Reovirus in CT26 Cells.
Rezazadeh A; Soleimanjahi H; Soudi S; Habibian A
Arch Razi Inst; 2022 Apr; 77(2):615-622. PubMed ID: 36284984
[TBL] [Abstract][Full Text] [Related]
13. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.
Guha P; Gardell J; Darpolor J; Cunetta M; Lima M; Miller G; Espat NJ; Junghans RP; Katz SC
Oncogene; 2019 Jan; 38(4):533-548. PubMed ID: 30158673
[TBL] [Abstract][Full Text] [Related]
14. Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells.
Han D; Yu T; Dong N; Wang B; Sun F; Jiang D
J Exp Clin Cancer Res; 2019 Jul; 38(1):289. PubMed ID: 31277685
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab promotes SN38 sensitivity via suppression of heat shock protein 27 in colorectal cancer cells with wild-type RAS.
Ishida T; Ishii Y; Tsuruta M; Okabayashi K; Akimoto S; Koishikawa K; Hasegawa H; Kitagawa Y
Oncol Rep; 2017 Aug; 38(2):926-932. PubMed ID: 28656305
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Reoviral Cytolysis (I): Combination Therapeutics.
Mori Y; Nishikawa SG; Fratiloiu AR; Tsutsui M; Kataoka H; Joh T; Johnston RN
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515160
[TBL] [Abstract][Full Text] [Related]
17. Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells.
Hong EH; Heo EY; Song JH; Kwon BE; Lee JY; Park Y; Kim J; Chang SY; Chin YW; Jeon SM; Ko HJ
Oncotarget; 2017 Jun; 8(25):41401-41411. PubMed ID: 28489607
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with
Goel S; Ocean AJ; Parakrama RY; Ghalib MH; Chaudhary I; Shah U; Viswanathan S; Kharkwal H; Coffey M; Maitra R
Mol Cancer Ther; 2020 May; 19(5):1148-1156. PubMed ID: 32156785
[No Abstract] [Full Text] [Related]
19. Oncolytic vaccinia virus synergizes with irinotecan in colorectal cancer.
Ottolino-Perry K; Acuna SA; Angarita FA; Sellers C; Zerhouni S; Tang N; McCart JA
Mol Oncol; 2015 Oct; 9(8):1539-52. PubMed ID: 26004084
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer.
Jiffry J; Thavornwatanayong T; Rao D; Fogel EJ; Saytoo D; Nahata R; Guzik H; Chaudhary I; Augustine T; Goel S; Maitra R
Clin Cancer Res; 2021 Feb; 27(3):865-876. PubMed ID: 33168658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
